Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion-positive lung cancer Meeting Abstract


Authors: Drilon, A.; Lin, J.; Lassen, U.; Leyvraz, S.; Liu, Y.; Patel, J.; Rosen, L.; Solomon, B.; Norenberg, R.; Dima, L.; Brega, N.; Shen, L.; Moreno, V.; Kummar, S.; Tan, D.
Abstract Title: Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion-positive lung cancer
Meeting Title: 2021 World Conference on Lung Cancer
Keywords: lung cancer; larotrectinib; ntrk gene fusions
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 10 Suppl.
Meeting Dates: 2021 Sep 8-14
Meeting Location: Virtual event
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S1125
End Page: S1126
Language: English
ACCESSION: WOS:000709606500550
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.08.551
Notes: Meeting Abstract: P53.02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    639 Drilon